BacterioLogix

BacterioLogix is a science-focused information brand exploring how gene editing and microbiome research may shape the future of health and food. Guided by the theme “reinventing the world’s food stream one gene at a time,” the site makes emerging biotechnology accessible through educational resources, articles, research papers, news, and project features. Its coverage includes CRISPR-Cas9, microbiomes, and bacteriophages, with particular attention to phage therapy.

BacterioLogix explains how bacteriophages selectively infect and destroy bacteria, and compares this approach with antibiotics, including concerns about antibiotic resistance and effects on beneficial bacteria. The site notes that phage therapy is not approved for people in the United States or Europe and that its use remains experimental. It also shares news about gene-editing research in areas such as cancer, infectious disease, organ transplantation, and agriculture. Visitors can explore FAQs, testimonials, scientific resources, and articles, as well as learn about the organization’s team and mission. Overall, BacterioLogix presents biotechnology developments and related research for readers seeking an approachable guide to these evolving fields.